These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 29666896

  • 1. Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition.
    Liu Y, Liu B, Zhang GQ, Zou JF, Zou ML, Cheng ZS.
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jul; 391(7):695-704. PubMed ID: 29666896
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitro.
    Zou M, Zhang G, Zou J, Liu Y, Liu B, Hu X, Cheng Z.
    Exp Cell Res; 2020 Jun 01; 391(1):111886. PubMed ID: 32017927
    [Abstract] [Full Text] [Related]

  • 3. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF, Kao KC, Liu YY, Lin CW, Chen NH, Lee CS, Wang CW, Yang CT.
    J Cell Mol Med; 2017 Nov 01; 21(11):2937-2949. PubMed ID: 28598023
    [Abstract] [Full Text] [Related]

  • 4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 5. The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C, Tabata R, Nakano T.
    Clin Exp Immunol; 2010 Dec 02; 162(3):560-7. PubMed ID: 20846163
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT).
    Rong L, Wu J, Wang W, Zhao RP, Xu XW, Hu D.
    Eur Rev Med Pharmacol Sci; 2016 May 02; 20(10):2144-50. PubMed ID: 27249616
    [Abstract] [Full Text] [Related]

  • 12. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.
    Acta Pharmacol Sin; 2016 Jun 02; 37(6):794-804. PubMed ID: 27133302
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
    Jin M, Wu Y, Wang L, Zang B, Tan L.
    Phytother Res; 2016 Apr 02; 30(4):577-87. PubMed ID: 26777519
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
    Wang Y, Li R, Chen L, Tan W, Sun Z, Xia H, Li B, Yu Y, Gong J, Tang M, Ji Y, Yuan S, Shanglong Yao, Shang Y.
    Shock; 2015 Nov 02; 44(5):496-502. PubMed ID: 26196843
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH, Li M, Ma HF, Li W, Liu L, Yin Y, Zhou XM, Hou G.
    Life Sci; 2020 Jan 15; 241():117139. PubMed ID: 31809714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.